Transporting Antibodies Across the Blood-Brain Barrier to Treat Alzheimer's Disease

Researchers have developed a new method that uses antibody fragments encapsulated in nanomicelles which can cross the blood-brain barrier and reduce levels of amyloid-beta in the brains of mouse models of Alzheimer's disease.